CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 229 filers reported holding CONMED CORP in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $994,693 | -28.6% | 9,868 | -3.7% | 0.00% | -20.0% |
| Q2 2023 | $1,392,950 | -0.8% | 10,251 | -24.2% | 0.01% | 0.0% |
| Q1 2023 | $1,404,257 | -27.2% | 13,521 | -37.8% | 0.01% | +25.0% |
| Q4 2022 | $1,928,757 | +80.6% | 21,751 | +63.3% | 0.00% | -20.0% |
| Q3 2022 | $1,068,000 | -15.8% | 13,323 | +0.6% | 0.01% | -16.7% |
| Q2 2022 | $1,268,000 | -18.3% | 13,241 | +26.7% | 0.01% | -14.3% |
| Q1 2022 | $1,552,000 | +7.9% | 10,452 | +2.9% | 0.01% | +16.7% |
| Q4 2021 | $1,439,000 | +13.2% | 10,157 | +4.6% | 0.01% | 0.0% |
| Q3 2021 | $1,271,000 | +18.0% | 9,710 | +23.9% | 0.01% | +20.0% |
| Q2 2021 | $1,077,000 | -0.9% | 7,835 | -5.8% | 0.01% | 0.0% |
| Q1 2021 | $1,087,000 | +26.2% | 8,319 | +8.3% | 0.01% | +25.0% |
| Q4 2020 | $861,000 | +207.5% | 7,683 | +115.5% | 0.00% | +300.0% |
| Q3 2020 | $280,000 | +12.9% | 3,565 | +3.5% | 0.00% | 0.0% |
| Q2 2020 | $248,000 | – | 3,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
| Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
| Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
| Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
| EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
| Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
| MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
| Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
| EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |